Skip to content

Deep Versus Moderate Neuromuscular Blockade in Bariatric Surgery

Deep Versus Moderate Neuromuscular Blockade in Bariatric Surgery:

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06553066
Enrollment
50
Registered
2024-08-14
Start date
2024-08-31
Completion date
2026-08-31
Last updated
2024-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular Blockade

Brief summary

The aim of this study is to investigate the effect of depth of neuromuscular blockade on the surgical field, patient postoperative pain, intestinal motility, the incidence of postoperative nausea and vomiting and the effect of deep versus moderate neuromuscular blockade on postoperative atelectasis quantitatively using chest computed tomography.This is a prospective, randomized, controlled clinical-controlled study in patients ≥18 years old scheduled to undergo elective bariatric surgery.

Interventions

DRUGDeep neuromascular blockage

maintenance of a deep neuromuscular block with rocuronium, titrated to maintain a TOF count of 0, and a PTC between 1-2. Quality of surgical field conditions' assessed by a blind surgeon as a 5 points scale(Leiden scale : 1 indicates extremely poor conditions, 2 poor conditions, 3 acceptable conditions, 4, good conditions and 5 optimal conditions)

DRUGModerate neuromascular blockage

maintenance of a moderate neuromuscular block with rocuronium, titrated to maintain a TOF count of 1-2

Sponsors

University Hospital of Patras
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Caregiver)

Masking description

in the assessment of the surgical field quality surgeons are blind respect the level of neuromuscular block received by patients

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged ≥18 years ASA II-III who are to undergo planned laparoscopic bariatric surgery

Exclusion criteria

* ASA 4 patients * Maternal population * Patients who are not scheduled to receive general anesthesia, but some other type of anesthesia. * Contraindicated patients: administration of neuromuscular blockade, suppression of spontaneous respiration, and those with an indication for awake intubation or surgical airway. * Patients with neuromuscular diseases * Patients who refuse to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
impact of a deep neuromuscular blockade on surgical conditionsDuring surgeryimpact of a deep neuromuscular blockade (TOF count = 0 and posttetanic count \[PTC\] 1-2) and a moderate neuromuscular blockade (TOF count= 1 - 3) on intraoperative surgical conditions assessed by the surgeon as a 5 points scale

Secondary

MeasureTime frameDescription
Postoperative painfirst postoperative dayPain was measured four times in the PACU (at 15 min intervals starting upon arrival) and twice on the ward (8PM the day of surgery and 2 PM the next day).Pain was measured using an 11-point numerical rating scale (NRS), ranging from 0 (no pain) to 10 (most pain imaginable).
Mean arterial pressure (mmHg)intraoperative and in Postanesthesia care unitmeasured before induction to general anesthesia, immediately after induction and every 15 min until the end of operation and immediately after awareness.at 15 min intervals starting upon arrival in the post anesthesia care unit
PIPcmH20 ( Peak inspiratory pressure)intraoperativeRespiratory mechanical parameters were measured after intubation at suspine position, after insufflation of pneumoperitoneum , then the standard different positions of the patient ( Anti-Trendelenburg, supine, anti-trendelenburg and suspine position without premoperitoneum at the end of the procedure)
duration of surgery (hr)intrapostoperativefrom the incision to the last skin suture
The first flatus time (min)up to 5 daysthe first time that patient flatus postoperative
duration of anesthesia time (min)intraoperativetime from anesthesia induction to Extubation
Postoperative nausea and vomiting (PONV)until first postoperative dayincidence of PONV
Hospitalization time ( days)up to 2 weeksFROM ADMISSION TO HOSPITAL TO DISCHARGE
the effect of deep versus moderate neuromuscular blockade on postoperative atelectasis quantitatively using chest computed tomography.in the first six postoperative hoursquantitatively using chest computed tomography and expressed as percentage to total lung tissue volume
oxygen saturation (SpO2) %intraoperative and in Postanesthesia care unitmeasured before induction to general anesthesia, immediately after induction and every 15 min until the end of operation and immediately after awareness.at 15 min intervals starting upon arrival in the post anesthesia care unit
tidal volume (ml)IntraoperativeRespiratory mechanical parameters were measured after intubation at suspine position, after insufflation of pneumoperitoneum , then the standard different positions of the patient ( Anti-Trendelenburg, supine, anti-trendelenburg and suspine position without premoperitoneum at the end of the procedure)
Pplat cmH20 ( plateau pressure),IntraoperativeRespiratory mechanical parameters were measured after intubation at suspine position, after insufflation of pneumoperitoneum , then the standard different positions of the patient ( Anti-Trendelenburg, supine, anti-trendelenburg and suspine position without premoperitoneum at the end of the procedure)
dynamic compliance ml/cmH20,IntraoperativeRespiratory mechanical parameters were measured after intubation at suspine position, after insufflation of pneumoperitoneum , then the standard different positions of the patient ( Anti-Trendelenburg, supine, anti-trendelenburg and suspine position without premoperitoneum at the end of the procedure)
DP cmH20( Driving pressure)IntraoperativeRespiratory mechanical parameters were measured after intubation at suspine position, after insufflation of pneumoperitoneum , then the standard different positions of the patient ( Anti-Trendelenburg, supine, anti-trendelenburg and suspine position without premoperitoneum at the end of the procedure)
Resistance cmH20/L/secIntraoperativeRespiratory mechanical parameters were measured after intubation at suspine position, after insufflation of pneumoperitoneum , then the standard different positions of the patient ( Anti-Trendelenburg, supine, anti-trendelenburg and suspine position without premoperitoneum at the end of the procedure)
PEEP cmH20IntraoperativeRespiratory mechanical parameters were measured after intubation at suspine position, after insufflation of pneumoperitoneum , then the standard different positions of the patient ( Anti-Trendelenburg, supine, anti-trendelenburg and suspine position without premoperitoneum at the end of the procedure)
cumulative analgetid dose (mg)until 2 PM the next day of the surgerycumulative analgetid dose until 2 PM the next day of the surgery

Contacts

Primary ContactNikolas Drakos, MD
nikolasdrakos@hotmail.com+306998429336

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026